DXR FY 2021 Earnings — Daxor Corporation Revenue & Financial Results | Market Cap Arena

DXRDaxor Corporation

$58M

FY 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

-$3M+6.8% YoY

Gross Profit

-$4M138.3% margin

Operating Income

$5M-181.6% margin

Net Income

$5M-181.6% margin

EPS (Diluted)

$1.18

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$729,336

Balance Sheet

Total Assets

$25M

Total Liabilities

$4M

Stockholders' Equity

$21M

Cash & Equivalents

$710,700

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	-$3M	-$3M	+6.8%
Gross Profit	-$4M	-$3M	-3.5%
Operating Income	$5M	-$2M	+374.4%
Net Income	$5M	-$2M	+378.4%